Caplight Directory>Investors>MPM Capital>Mpmcapital


MPM Capital

MPM Capital

Boston, Massachusettsmpmcapital.com

Overview

MPM Capital, also known as MPM BioImpact, is a world-leading biotechnology investment firm with nearly three decades of experience. The firm creates and invests in private and public companies across all stages of development that seek to translate scientific innovations into cures for major diseases, with a particular focus on biotechnology, life sciences, and oncology. MPM BioImpact combines the venture capital activities of MPM Capital with the impact and public equity investing of its affiliate, BioImpact Capital. The firm has been involved in the development of 60 FDA-approved drugs.

Portfolio Companies

21

Investments

CompanyDateStageLead
Umoja BiopharmaJan 2025Series CCo-investor
Aktis OncologySep 2024Series BCo-investor
Frontier MedicinesFeb 2024Series CCo-investor
AstronauTxOct 2023Series ACo-investor
ReCode TherapeuticsSep 2023Series B ExtensionCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.